(Q42987473)

English

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

scientific article published on March 1998

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Fong TL

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Han SH

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tsai NC

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Morgan TR

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Mizokami M

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Qian D

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Phan C

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Goad K

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Redeker AG

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 March 1998

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

369-374

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to interferon alpha therapy is influenced by the iron content of the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Iron and chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Is hepatitis C virus infection a trigger of porphyria cutanea tarda?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

HCV infection in porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Porphyria cutanea tarda and antibodies to hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver damage in Italian patients with hereditary hemochromatosis is highly influenced by hepatitis B and C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurements of iron status in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980308-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0168-8278(98)80308-5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42987473&oldid=1591418219"